Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrug ▼Date fromSubject
 13.11.2025Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)4771BAbilify Maintena 400 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním v naplnenej injekčnej striekačke (plu igf 1x400 mg+1x1,6 ml (striek.inj.skl.napl.))13.11.2025R
 26.6.2025Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)6077EAbilify Maintena 960 mg injekčná suspenzia s predĺženým uvoľňovaním v naplnenej injekčnej striekačke (sus iph 1x960 mg (striek.inj.napl + 2 bezp.ihly))1.8.2025U
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7951DAbiraterón Sandoz 1000 mg filmom obalené tablety (tbl flm 30x1000 mg (blis.Al/OPA/Al/PVC))12.2.2024O
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7951DAbiraterón Sandoz 1000 mg filmom obalené tablety (tbl flm 30x1000 mg (blis.Al/OPA/Al/PVC))25.10.2023R
 27.10.2025Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7942DAbiraterón Sandoz 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.Al/PVC/PE/PVDC))27.10.2025R
 17.3.2023G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))15.3.2023O
 18.1.2024G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))18.1.2024R
 15.2.2023G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))16.2.2023R
 13.3.2024G.L. Pharma GmbH (GLH-2)8712DAbiraterone G.L. Pharma 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.PVC/PVDC/Al))4.3.2024O
 9.5.2023medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)8030DAbiraterone medac 500 mg filmom obalené tablety (tbl flm 56x500 mg (blis.PVC/PVDC/Al))11.5.2023U
 6.9.2024Mylan Ireland Limited (MNY)8549DAbiraterone Mylan 500 mg filmom obalené tablety (tbl flm 60x500 mg (blis.Al/PVC/PE/PVDC))30.11.2024Z
 3.3.2023Pharmevid s.r.o. (PEV)1420EAbiraterone Pharmevid 250 mg tablety (tbl 120x250 mg (fľ.HDPE))8.3.2023U
 7.11.2022Vipharm S.A. (VIH-PL-1)8608DAbiraterone Vipharm 500 mg (tbl flm 60x500 mg (blis.PVC/PVDC/Al))8.11.2022U
 27.9.2022Zentiva, k.s. (ZNT-1)9158DAbiraterone Zentiva (tbl flm 60x500 mg (blis.PVC/PVDC/Al))27.9.2022U
 13.11.2024Glenmark Pharmaceuticals s.r.o. (GLM-CZ)4283EAbisax 20 mg (tbl 30x20 mg (blis.Al/Al))14.11.2024U

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)